Thomas LeBlanc. MD, MA of Duke Cancer Institute leads a discussion around strategies for managing patients with myelodysplastic syndromes in patients who experience ESA failure or are ineligible for ESA therapy. Leblanc is joined by Andrew Brunner, MD of Massachusetts General Hospital, and Jamie Koprivnikar, MD of Hackensack University Medical Center.
----------
Blood Cancers Today is a new publication that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
Blood Cancers Today was developed to reach all professionals in the hematology/oncology universe, covering the latest news and analysis in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, and other hematologic malignancies.
